Candel Therapeutics (NASDAQ:CADL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says
Candel Therapeutics (NASDAQ:CADL – Get Free Report) had its price target upped by stock analysts at Canaccord Genuity Group from $20.00 to $25.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price points to a potential upside of 190.70% from the company’s […]
Candel Therapeutics (NASDAQ:CADL – Get Free Report) had its price target upped by stock analysts at Canaccord Genuity Group from $20.00 to $25.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price points to a potential upside of 190.70% from the company’s […]
